FID-007 in Treating Participants With Advanced Solid Tumors

NCT03537690 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Refractory Malignant Solid Neoplasm

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: PEOX-based Polymer Encapsulated Paclitaxel FID-007
OTHER: Pharmacokinetic Study

Sponsor

University of Southern California

Collaborators

National Cancer Institute (NCI)